As of 2025-07-17, the Fair Value of Relay Therapeutics Inc (RLAY) is -9.72 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.64 USD, the upside of Relay Therapeutics Inc is -367.12%.
With the market price of 3.64 USD and our fair value calculation, Relay Therapeutics Inc (RLAY) is not a good investment. Investing in RLAY stocks now will result in a potential loss of 367.12%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -52.41 | -363.87 | -290.51 | -341.97 | -337.71 | -277.29 |
| YoY growth | 30.41% | -594.28% | 20.16% | -17.71% | 1.25% | -112.03% |
| Market Cap (mil) | 624.04 |
| P/E | |
| Forward P/E |
| EPS | -1.94 |
| Avg earnings growth rate | -112.03% |
| TTM earnings | -333.39 |